Publication | Closed Access

Synthesis, crystal structure analysis, spectral investigations (NMR, FT-IR, UV), DFT calculations, ADMET studies, molecular docking and anticancer activity of 2-(1-benzyl-5-methyl-1H-1,2,3-triazol-4-yl)-4-(2-chlorophenyl)-6-methoxypyridine – A novel potent human topoisomerase IIα inhibitor

Molecular DockingMedicinal ChemistryMedicineRational Drug DesignSpectral InvestigationsPharmacotherapyAnti-cancer AgentAdmet StudiesDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug Discovery